Liquid Biopsy Revolutionizing Cancer Care, But Costs Continue To Inhibit Global Potential
For much of the world, the full promise of liquid biopsy exceeds purchasing power.
Liquid biopsy represents potential advantages over traditional approaches to cancer surveillance, treatment selection and recurrence monitoring. But one size does not fit all, requiring tailored solutions for less developed markets.
